(NASDAQ:CPRX), CORAL GABLES, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that Rich Daly, President and CEO, along with other members of Catalyst's management team, will […]

REI Systems, a leading provider of innovative technology solutions for the government, announced the launch of GovSBIR, the first comprehensive, intelligent platform designed to modernize and streamline the full lifecycle of the federal government's Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. https://mma.prnewswire.com/media/364170/rei_systems_logo.jpg Built on REI's trusted GovGrants® framework and leveraging

The Gulf South Business Roundtable (GSBR) announced that Boardwalk Pipelines and Mississippi Power have joined its growing network of member companies committed to advancing economic competitiveness and responsible growth across the Gulf South. https://mma.prnewswire.com/media/2825653/GSBR_Logo.jpg Together, these organizations represent essential sectors that power the region's energy infrastructure, drive job creation, and strengthen communities through innovation and

AI breakthroughs, rising infrastructure demands, and social-first content are breaking down industry walls – reshaping how businesses build, connect, and entertain https://mma.prnewswire.com/media/2825207/Deloitte_Technology_Media_and_Telecommunications_Predictions_report.jpg Key takeaways — Agents assemble: The global agentic AI market could reach $45 billion in 2030, but only if enterprises and providers perform proper orchestration. — AI disrupts search: Daily usage of AI

One-day event will spotlight a curated assortment of 400+ holiday food and drink offerings, all available in stores this season at prices worth celebrating Inspired by its unmatchedfandom, this holiday season, ALDI is sharing a taste of its unmatched assortment (and prices) at its first-ever 'A Very ALDI Holiday Pop-Up.' The brand is stepping into

Coughlin Brings Nearly 30 Years of Financial Operational Experience Tom Barry to Step Down, Effective December 31 Sirius XM Holdings Inc. (NASDAQ: SIRI) today announced that it has appointed Zac Coughlin as the Company's next Chief Financial Officer, effective January 1, 2026. Coughlin will succeed Tom Barry who is stepping down as SiriusXM's CFO. https://mma.prnewswire.com/media/2298536/SIRI_Logo.jpg

NEW YORK, NY / ACCESS Newswire / November 18, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding WPP plc (NYSE:WPP) class action securities lawsuit A Class Action lawsuit was filed on behalf of WPP plc investors who lost money as a result of alleged securities fraud between February 27, 2025 and July 8,

Catalyst Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference GlobeNewswire November 18, 2025 CORAL GABLES, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that Rich

Moment Energy, one of North America's leading EV battery repurposing companies, today announced it has secured $5 million in growth financing from TD Innovation Partners (TDIP), the innovation banking division of The Toronto-Dominion Bank. https://mma.prnewswire.com/media/2825291/Moment_Energy_Moment_Energy_Secures__5_Million_in_Debt_Financing.jpg The funding underscores the growing institutional support for Canadian clean technology companies as they advance the global transition to clean,

VIVJOA provided nearly 2 years of sustained efficacy against RVVC in a long-term extension of Phase 3 studies Mycovia Pharmaceuticals, Inc. (“Mycovia”) has announced the publication of long-term efficacy results from an extension study of the VIOLET Phase 3 clinical program which evaluated VIVJOA (oteseconazole) capsules in women with RVVC in the Journal of Women's